Screens and evaluates the safety of novel bacterial strains as probiotics, suggesting their potential for food and health applications.
This study aimed to screen novel bacterial strains available in the laboratory, derived from previous research, for potential probiotic attributes and safety. Primary screening included microscopic and biochemical characterization using Gram, negative, and endospore staining, along with oxidase and catalase assays. Safety evaluation involved hemolysis and serum coagulation tests. Most of the tested isolates were Gram-positive, bacilli, non-spore-forming, oxidase- and catalase-negative, and coagulase-negative. The majority displayed gamma hemolysis, indicating nonpathogenic nature, while some showed alpha or beta hemolysis. Five out of nine isolates were non-hemolytic and salt-tolerant up to 2.5%. Among nine tested isolates, five exhibited high salt tolerance and favorable probiotic properties, suggesting their potential use in food preservation and supplementation. The non-hemolytic and coagulase-negative characteristics of these strains indicate safety for human application. Further in-vivo studies are planned to assess their gastrointestinal survivability and health-promoting potential.
No takes yet. Share an insight, caveat, or question.
Jadeja et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: